Loading...
Loading...
Browse all stories on DeepNewz
VisitCompany facing most regulatory scrutiny for Bausch + Lomb acquisition by March 31, 2025?
TPG • 25%
Blackstone • 25%
Bausch + Lomb • 25%
None • 25%
Regulatory filings, news reports from major financial news outlets
TPG ($TPG) and Blackstone ($BX) Team Up for Bausch + Lomb ($BLCO) Bid in Potential $14 Billion Deal
Oct 14, 2024, 09:22 AM
Private equity groups TPG ($TPG) and Blackstone ($BX) have teamed up to work on a joint bid for eyecare company Bausch + Lomb ($BLCO). If successful, the deal could be one of the largest private equity buyouts of the year. Offers are expected to reach up to $25 per share, valuing the company between $13 billion and $14 billion. This move comes as Bausch Health looks to resolve financial challenges. Additionally, Bausch + Lomb recently received FDA approval for its enVista® Envy™ Full Range of Vision Intraocular Lens.
View original story